U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Reduce the proportion of adults with chronic kidney disease who have elevated blood pressure — CKD‑06

Status: Little or no detectable change

  
Little or no detectable change
Learn more about our data release schedule

Most Recent Data:
44.4 percent (2017-20) *

Target:
39.8 percent 1  *

Desired Direction:
Decrease desired

Baseline:
44.8 percent of adults aged 18 years and over with chronic kidney disease had elevated blood pressure in 2013-16 2 *

*  Age adjusted to the year 2000 standard population.

See detailed data for this objective

Reduce the proportion of adults with chronic kidney disease who have elevated blood pressure

Target-Setting Method
Minimal statistical significance

Data Source:  National Health and Nutrition Examination Survey (NHANES), CDC/NCHS

Learn more about data measurement for this objective

Summary

When people with chronic kidney disease (CKD) have untreated high blood pressure, it can lead to heart problems, end-stage kidney disease (ESKD), and early death. Improving blood pressure control in people with CKD can help prevent or delay ESKD. Evidence shows that ACE (angiotensin-converting enzyme) inhibitors and ARBs (angiotensin II receptor blockers) can lower blood pressure and reduce kidney damage.

Topics:  Chronic Kidney Disease, Heart Disease and Stroke

Workgroup: Chronic Kidney Disease Workgroup

Other objectives you may be interested in

Browse all Healthy People 2030 objectives

1. Target has been revised. See Data Methodology and Measurement for more information.

2. Baseline has been revised. See Data Methodology and Measurement for more information.